Wiley

MedComm Template

Write in a clean editor, then format for MedComm in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the MedComm format

MedComm is a peer-reviewed journal published by Wiley, covering Cancer Immunotherapy and Biomarkers, Immune cells in cancer, RNA modifications and cancer.

PublisherWiley
Reference styleAuthor–year (Chicago)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." MedComm 12 (3): 45–58.

Formats any DOI in MedComm style. No sign-up.

Publishes research inCancer Immunotherapy and Biomarkers Immune cells in cancer RNA modifications and cancer SARS-CoV-2 and COVID-19 Research Epigenetics and DNA Methylation
ISSN2688-2663
Citation impact (2-yr)9.58
h-index74
i10-index575
Total citations29,646
Article processing charge$2,900
Open accessYes
Top institutions publishing hereSichuan University
Journal websiteonlinelibrary.wiley.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in MedComm per year

1
2003
1
2005
1
2007
1
2012
1
2013
1
2014
49
2020
65
2021
93
2022
258
2023
366
2024
533
2025

Citation impact of MedComm by publication year

12
2003
0
2005
0
2007
0
2012
7
2013
0
2014
1.5K
2020
3.2K
2021
4.3K
2022
8.8K
2023
6.6K
2024
3.9K
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in MedComm

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

Chen Hu, Jing Yang, Ziping Qi et al. · 2 Aug 2022

The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect cells from stresses. HSP protein families are classified based on their molecular weights, mainly including large HSPs, HSP90, HSP70, HSP60, HSP40, and small HSPs. They function as molecular chaperons in cells…

Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models

Lihui Xuan, Zhao Ju, Magdalena Skonieczna et al. · 14 Jul 2023

Nanoparticles (NPs) have become one of the most popular objects of scientific study during the past decades. However, despite wealth of study reports, still there is a gap, particularly in health toxicology studies, underlying mechanisms, and related evaluation models to deeply understanding the NPs risk effects. In this review, we first present a comprehensive landscape…

NF‐κB signaling in inflammation and cancer

Tao Zhang, Chao Ma, Zhiqiang Zhang et al. · 1 Dec 2021

Since nuclear factor of κ-light chain of enhancer-activated B cells (NF-κB) was discovered in 1986, extraordinary efforts have been made to understand the function and regulating mechanism of NF-κB for 35 years, which lead to significant progress. Meanwhile, the molecular mechanisms regulating NF-κB activation have also been illuminated, the cascades of signaling events leading to…

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

Xuemei He, Weiqi Hong, Xiangyu Pan et al. · 1 Dec 2021

Coronavirus disease 2019 (COVID-19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in COVID-19 cases. On November 24, 2021, B.1.1.529 named Omicron was designated as a variant under monitoring (VUM)…

Applications of multi‐omics analysis in human diseases

Chongyang Chen, Jing Wang, Donghui Pan et al. · 31 Jul 2023

Multi-omics usually refers to the crossover application of multiple high-throughput screening technologies represented by genomics, transcriptomics, single-cell transcriptomics, proteomics and metabolomics, spatial transcriptomics, and so on, which play a great role in promoting the study of human diseases. Most of the current reviews focus on describing the development of multi-omics technologies, data integration, and application…

MedComm template — frequently asked questions

How do I write a paper in the MedComm format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the MedComm template. When you export, DocuGuru compiles the paper into the official Wiley format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does MedComm use?
MedComm uses Author–year (Chicago) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." MedComm 12 (3): 45–58.
Do I need to know LaTeX to submit to MedComm?
No. DocuGuru generates the USG LaTeX class and compiles the PDF for you in the background, so you get a Wiley-ready MedComm document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the MedComm template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the MedComm format with correct headings, figures, tables, and author–year citations.
Who publishes MedComm?
MedComm is a multidisciplinary journal published by Wiley. DocuGuru's MedComm template matches Wiley's official submission format.
Can I export a submission-ready MedComm PDF?
Yes — DocuGuru produces a PDF built with the official MedComm template (the USG class) that is ready to submit to Wiley, together with the matching LaTeX source files.
How much does the MedComm template cost?
You can start writing in the MedComm template for free. Exporting the final submission-ready MedComm PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the MedComm template